{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T02:32:31Z","timestamp":1771986751213,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.atherosclerosis.2013.09.019","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T17:37:17Z","timestamp":1380735437000},"page":"223-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Familial hypercholesterolaemia: A pressing issue for European health care"],"prefix":"10.1016","volume":"231","author":[{"given":"Philippa","family":"Brice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher W.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve E.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Aitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib1","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus Statement of the European Atherosclerosis Society","volume":"15","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib2","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2013.09.019_bib5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jmedgenet-2012-101189","article-title":"Use of targeted exome sequencing as a diagnostic tool for familial hypercholesterolaemia","volume":"49","author":"Futema","year":"2012","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2013.09.019_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","article-title":"Mechanisms of disease: genetic causes of familial hypercholesterolemia","volume":"4","author":"Soutar","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"9874","key":"10.1016\/j.atherosclerosis.2013.09.019_bib7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2013.09.019_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacl.2010.08.015","article-title":"Novel therapies and new targets of treatment for familial hypercholesterolemia","volume":"4","author":"Goldberg","year":"2010","journal-title":"J\u00a0Clin Lipidol"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2013.09.019_bib9","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.112.144055","volume":"126","author":"Raal","year":"2012","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2013.09.019_bib10","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib11","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"issue":"9406","key":"10.1016\/j.atherosclerosis.2013.09.019_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)15467-6","article-title":"Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia","volume":"363","author":"Wiegman","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2013.09.019_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2165\/11632810-000000000-00000","article-title":"Drug therapy of hypercholesterolaemia in children and adolescents","volume":"72","author":"Braamskamp","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","article-title":"A\u00a0review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia","volume":"168","author":"Marks","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib15","series-title":"Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia","author":"National Institute for Health and Clinical Excellence","year":"2008"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.12.001","article-title":"The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population","volume":"180","author":"Damgaard","year":"2005","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2013.09.019_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2013.09.019_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1469-1809.2012.00724.x","article-title":"Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment","volume":"76","author":"Usifo","year":"2012","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCGENETICS.111.962456","article-title":"Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH","volume":"5","author":"Huijgen","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib20","doi-asserted-by":"crossref","first-page":"d520","DOI":"10.1136\/bmj.d520","article-title":"Families at risk of genetically high cholesterol are not being spotted, says royal college","volume":"342","author":"Mooney","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/hrt.2010.213975","article-title":"Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies","volume":"97","author":"Nherera","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib22","series-title":"Diagnostics guidance 2: elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia","author":"National Institute for Health and Clinical Excellence","year":"2011"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib23","series-title":"Saving lives, saving families the health, social and economic advantages of detecting and treating familial hypercholesterolaemia (FH)","author":"Heart","year":"2012"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2013.09.019_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1373\/clinchem.2011.173963","article-title":"Microfluidic amplification as a tool for massive parallel sequencing of the familial hypercholesterolemia genes","volume":"58","author":"Hollants","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2013.55","article-title":"The use of next-generation sequencing in clinical diagnosis of familial hypercholesterolemia","author":"Vandrovcova","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib27","series-title":"DNA tests to revolutionise fight against cancer and help 100,000 NHS patients","author":"Prime Minister's Office, 10 Downing Street","year":"2012"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib28","series-title":"Gateway reference 18747","author":"Department of Health Cardiovascular Disease Outcomes Strategy","year":"2013"},{"key":"10.1016\/j.atherosclerosis.2013.09.019_bib29","series-title":"Familial hypercholesterolaemia","author":"National Institute for Health and Clinical Excellence","year":"2013"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013005650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013005650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T12:54:50Z","timestamp":1539348890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013005650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0021915013005650"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.09.019","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial hypercholesterolaemia: A pressing issue for European health care","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}